ÂÜÀòÂÒÂ×

Anthony Wild, PhD, is an investor in and on the boards of a number of privately held healthcare companies in the US and Europe, helping to found BOWS Pharma of Switzerland, as well as Sprout Pharmaceuticals and Slate Pharmaceuticals in the US.

Prior to this, Dr. Wild was a founder of MedPointe Pharmaceuticals Inc., formed in 2001 around the acquisition of the Carter-Wallace Company and became its chairman and first CEO. MedPointe was successfully sold in August 2007 to MEDA AB of Sweden.